# Bengbu Medical College

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/bengbu-medical-college/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 47.2 |
| Citations | 315,374 |
| City | Bengbu |
| Country | CN |
| Description | Bengbu Medical College is a research organisation in Bengbu, CN. OpenAlex records 12,302 works and 315,374 citations for it. 5,981 researchers list it as their most recent affiliation. |
| Homepage | https://www.bbmc.edu.cn |
| OpenAlex ID | https://openalex.org/I169351748 |
| Researchers | 5,981 |
| ROR ID | https://ror.org/01f8qvj05 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q4887726 |
| Works | 12,302 |

## University papers

Showing 12 of 23.

- [The challenge of mapping the human connectome based on diffusion tractography](https://scholariq.org/papers/the-challenge-of-mapping-the-human-connectome-based-on-diffusion-tractography/)
- [COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas](https://scholariq.org/papers/covid-19-immune-features-revealed-by-a-large-scale-single-cell-transcriptome/)
- [Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)](https://scholariq.org/papers/guidelines-for-diagnosis-and-treatment-of-primary-liver-cancer-in-china-2017/)
- [Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction](https://scholariq.org/papers/circulating-microrna-1-as-a-potential-novel-biomarker-for-acute-myocardial/)
- [Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/atezolizumab-plus-bevacizumab-versus-active-surveillance-in-patients-with/)
- [Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial](https://scholariq.org/papers/intensive-blood-pressure-reduction-with-intravenous-thrombolysis-therapy-for/)
- [Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance](https://scholariq.org/papers/reciprocal-leukemia-stroma-vcam-1-vla-4-dependent-activation-of-nf-b-mediates/)
- [Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial](https://scholariq.org/papers/intensive-blood-pressure-control-after-endovascular-thrombectomy-for-acute/)
- [Iron-dependent histone 3 lysine 9 demethylation controls B cell proliferation and humoral immune responses](https://scholariq.org/papers/iron-dependent-histone-3-lysine-9-demethylation-controls-b-cell-proliferation/)
- [I<sub>2</sub>/TBPB Mediated Oxidative Reaction of <i>N</i>-Tosylhydrazones with Anilines: Practical Construction of 1,4-Disubstituted 1,2,3-Triazoles under Metal-Free and Azide-Free Conditions](https://scholariq.org/papers/i-sub-2-sub-tbpb-mediated-oxidative-reaction-of-i-n-i-tosylhydrazones-with/)
- [Enantioselective α‐Benzylation of Acyclic Esters Using π‐Extended Electrophiles](https://scholariq.org/papers/enantioselective-benzylation-of-acyclic-esters-using-extended-electrophiles/)
- [Neuroprotective Effects of Endurance Exercise Against High‐Fat Diet‐Induced Hippocampal Neuroinflammation](https://scholariq.org/papers/neuroprotective-effects-of-endurance-exercise-against-high-fat-diet-induced/)

## University researchers

- [Chao Yang](https://scholariq.org/researchers/chao-yang/)
- [Tiantian Bai](https://scholariq.org/researchers/tiantian-bai/)
- [Xing Wei](https://scholariq.org/researchers/xing-wei/)
- [Ningning Xue](https://scholariq.org/researchers/ningning-xue/)

## University top topics

Showing 8 of 23.

- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Circular RNAs in diseases](https://scholariq.org/topics/circular-rnas-in-diseases/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.